LABIXIAOXIN (01262) announced that the Group expects to achieve an after-tax profit of approximately RMB 2 million for the six months ended June 30, 2025, compared to an after-tax loss of RMB 43.6 million in the corresponding period of 2024. The increase in after-tax profit is attributed to reduced advertising and promotional expenses and lower expected credit loss provisions for the six months ended June 30, 2025, compared to the same period in 2024.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.